|Articles|April 1, 2020
PHARMASEAL Offering No Cost CTMS for COVID-19 Clinical Trials
Advertisement
PHARMASEAL International has announced that it will offer the Engility CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The offer is open to biopharmaceutical organizations and academic institutions.
For more information, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
3
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
4
What Clinical Trials Can Learn from the Gig Economy About Payments
5